mdi Consultants, Inc. Internationally Recognized Consulting Company to the MEDICAL DEVICE/IVD/PHARMACEUTICAL INDUSTRIES

mdi Consultants Inc. has the expertise and can provide you exceptional professional aid in the following areas:


Assist in FDA regulatory strategies – Pre-Sub, 513(g) and 510(K)s

· US Agent Services and Official Correspondent for Foreign Companies

. FDA EUA and conversion to 510 (k)s, Drug registration for Disinfectants

· MDSAP (Medical Device Single Audit Program) – implementation and preparation

· 510(k)/PMA/ANDA/NDA/DMF/IDE Planning - Preparation and Submission

· FDA compliance  - Regulatory strategy development, Pre-Sub, clinical trial development/ management, cGMP compliance, ISO, CE Mark, On-site audits, validation (process, software and sterilization)

. Assisting with “Breakthrough” Designation and working with AI devices

. Assisting with FDA inspections – prior to and during the FDA inspection

· FDA Troubleshooting and CRISIS INTERVENTION - Response to 483 and Warning letters – FDA mitigation

· UDI & GUDID Compliance

mdi leverages a proven and tested methodology with seasoned
and experienced consultants.

With over 200 years of cumulative industry experience on staff, we have delivered the following results: Helped over 500 companies achieve FDA compliance and/or ISO certification with 100% success in first time ISO certification and CE mark for over 1000 products Successfully prepared and submitted over a 3500 510(k) applications.

CONTACT INFOMATION 

Main Office:
55 Northern Blvd,

Great Neck,

NY 11021


(Tel.) 516-482 9001

(Fax) 516-482-0186
Email:  info@mdiconsultants.com
Website:  www.mdiconsultants.com

Go to article: Home | Point-of-Care diagnosticsGo to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: PAMA Manufacturing and SterilizationGo to article: BriefingGo to article: Industry newsGo to article: The medical industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: SartoriusGo to article: PicosunGo to article: CommentGo to article: No shortage of hurdles to overcome for implementation of IVDR in Europe for 2022Go to article: Orthopaedics trends: Tendon most mentioned term on Twitter Q4 2021Go to article: The growing elder population will continue to drive the global medical device maGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: In DepthGo to article: Patient advisors: could they change the face of medtech trials?Go to article: New UK medical device regulation spells potential trial concernsGo to article: Point-of-Care diagnostics: A boon awaits under remote healthcareGo to article: “Greener” choices in inhalers garner increasing pharma, device company supportGo to article: mdi ConsultantsGo to article: In DataGo to article: Artificial intelligence hiring in the medical industry rose in January 2022Go to article: J&J top innovator at tail end of 2021Go to article: January 2022 saw a 33% drop in medical devices’ approval in the USGo to article: EventsGo to article: Next Issue